Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9e96d119f3d9a192ef9ea11be70ec231 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e176e856cbede58adc4579967df6e9f9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3d3daf1fc50824ee70a75094c4fe9819 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-1723 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2210-125 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2230-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-3561 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-3523 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36585 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-14276 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-172 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-142 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-362 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-365 |
filingDate |
2010-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3d376e40b8d48338e53a43f9e4cf8d5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ca5964d6e1af02882596633b2f015bd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_910410dd6e6c40d1595288e6d29a88f5 |
publicationDate |
2010-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2010286592-A1 |
titleOfInvention |
Method to modulate cellular regeneration post myocardial infarct |
abstract |
A system delivers cardiac pacing therapy and chemical and/or biological therapy to modulate myocardial tissue growth in a heart after myocardial infarction (MI). The system includes an agent delivery device to release one or more agents to an MI region to modulate myocardial tissue growth in that region, and a cardiac rhythm management (CRM) device to deliver pacing pulses to enhance the effects of the one or more agents by altering myocardial wall stress and cardiac workload. In one embodiment, the system is an implantable system including an implantable agent delivery device and an implantable CRM device. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2016249244-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8346356-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009005658-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9968734-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10010670-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9700669-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8805492-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8712520-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010069977-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010069984-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8718764-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010069980-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8634910-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8538520-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018513487-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013148122-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016168635-A1 |
priorityDate |
2004-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |